ACRS vs TECH · rev $18.7M vs P/E 65, rev $1.22B
Aclaris Therapeutics Inc (ACRS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ACRS currently screens at market cap $615.9M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ACRS and TECH stock pages for the full models.
Not investment advice.